| Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers L Almeida, M Vaz‐da‐Silva, A Falcão, E Soares, R Costa, AI Loureiro, ... Molecular nutrition & food research 53 (S1), S7-S15, 2009 | 516 | 2009 |
| Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: a randomized, double‐blind, placebo‐controlled … C Elger, P Halász, J Maia, L Almeida, P Soares‐da‐Silva, ... Epilepsia 50 (3), 454-463, 2009 | 316 | 2009 |
| Catechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease MJ Bonifácio, PN Palma, L Almeida, P Soares‐da‐Silva CNS drug reviews 13 (3), 352-379, 2007 | 272 | 2007 |
| Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy E Ben-Menachem, AA Gabbai, A Hufnagel, J Maia, L Almeida, ... Epilepsy research 89 (2-3), 278-285, 2010 | 233 | 2010 |
| Eslicarbazepine acetate (BIA 2-093) L Almeida, P Soares-da-Silva Neurotherapeutics 4, 88-96, 2007 | 229 | 2007 |
| Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures A Gil‐Nagel, J Lopes‐Lima, L Almeida, J Maia, P Soares‐da‐Silva, ... Acta Neurologica Scandinavica 120 (5), 281-287, 2009 | 203 | 2009 |
| Eslicarbazepine acetate: a double‐blind, add‐on, placebo‐controlled exploratory trial in adult patients with partial‐onset seizures C Elger, M Bialer, JA Cramer, J Maia, L Almeida, P Soares‐da‐Silva Epilepsia 48 (3), 497-504, 2007 | 163 | 2007 |
| Effect of food on the pharmacokinetic profile of trans-resveratrol M Vaz-da-Silva, AI Loureiro, A Falcao, T Nunes, JF Rocha, ... Int J Clin Pharmacol Ther 46 (11), 564-70, 2008 | 129 | 2008 |
| Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects L Almeida, PS da Silva, A Falcão, J Maia, D Mazur, M Gellert | 129 | 2005 |
| Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects T Nunes, L Almeida, JF Rocha, A Falcão, C Fernandes‐Lopes, ... The Journal of Clinical Pharmacology 49 (12), 1477-1482, 2009 | 125 | 2009 |
| Long‐term efficacy and safety of eslicarbazepine acetate: results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy P Halász, JA Cramer, D Hodoba, A Członkowska, A Guekht, J Maia, ... Epilepsia 51 (10), 1963-1969, 2010 | 117 | 2010 |
| Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment L Almeida, JH Potgieter, J Maia, MA Potgieter, F Mota, P Soares-da-Silva European journal of clinical pharmacology 64, 267-273, 2008 | 117 | 2008 |
| Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects: Prediction of Slow … L Almeida, JF Rocha, A Falcão, P Nuno Palma, AI Loureiro, R Pinto, ... Clinical pharmacokinetics 52, 139-151, 2013 | 110 | 2013 |
| Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate J Maia, L Almeida, A Falcao, E Soares, F Mota, MA Potgieter, JH Potgieter, ... International journal of clinical pharmacology and therapeutics 46 (3), 119, 2008 | 100 | 2008 |
| Why healthy subjects volunteer for phase I studies and how they perceive their participation? L Almeida, B Azevedo, T Nunes, M Vaz-da-Silva, P Soares-da-Silva European journal of clinical pharmacology 63, 1085-1094, 2007 | 98 | 2007 |
| Opicapone: a short lived and very long acting novel catechol‐O‐methyltransferase inhibitor following multiple dose administration in healthy subjects JF Rocha, L Almeida, A Falcão, PN Palma, AI Loureiro, R Pinto, ... British journal of clinical pharmacology 76 (5), 763-775, 2013 | 95 | 2013 |
| Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: integrated analysis of pooled data from double‐blind phase III … A Gil‐Nagel, C Elger, E Ben‐Menachem, P Halász, J Lopes‐Lima, ... Epilepsia 54 (1), 98-107, 2013 | 95 | 2013 |
| Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open … A Hufnagel, E Ben-Menachem, AA Gabbai, A Falcão, L Almeida, ... Epilepsy Research 103 (2-3), 262-269, 2013 | 92 | 2013 |
| The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis L Cabral, V Afreixo, L Almeida, JA Paiva PLoS ONE 11 (12), e0168475, 2016 | 88 | 2016 |
| Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers T Nunes, JF Rocha, A Falcão, L Almeida, P Soares‐da‐Silva Epilepsia 54 (1), 108-116, 2013 | 76 | 2013 |
Christian ElgerProfessor für Epileptologie, Universität Bonn在 betaklinik.de 的电子邮件经过验证
